AUG 11, 2022 7:45 AM PDT

New Tuberculosis Vaccine Enters Phase III Clinical Trial

WRITTEN BY: Zoe Michaud

Tuberculosis is a disease caused by the bacterium Mycobacterium tuberculosis. It is spread through the air when a person with M. tuberculosis bacteria in their lungs coughs or speaks. From the lungs, Tuberculosis can spread and infect other areas of the body including the kidneys, spine, and brain. 

Symptoms of Tuberculosis vary depending on where in the body the bacteria is growing. Most commonly, M. tuberculosis bacteria in the lungs can lead to a severe cough and chest pain. Tuberculosis is more likely to have a severe effect on people with other risk factors, including children, the elderly, and those with a compromised immune system.

There is currently one Tuberculosis vaccine available. The vaccine, called Bacille Calmette-Guérin (BCG), has a number of limitations. The BCG vaccine does not prevent a primary infection and does not prevent reactivation of a latent pulmonary infection of M. tuberculosis. For these reasons, the medical community has continued to investigate more effective vaccine options for preventing the infection and transmission of Tuberculosis. 

A Tuberculosis vaccine developed by researchers at the Max Planck Institute has recently entered a clinical trial in South Africa. Initial vaccine trials have shown the vaccine to be more effective and to have fewer side effects than the BCG vaccine. In the phase II trial, 416 eligible newborns were vaccinated. 312 newborns in the cohort received the new vaccine (currently called VPM1002) while the remaining 104 received the BCG vaccine. Fewer vaccine-related adverse reactions were seen in the group that received VPM1002. 

The subsequent phase III trial will investigate how effective the vaccine is in protecting against a Tuberculosis infection. The researchers expect these results to be available in about three years. Umesh Shaligram, Executive Director of R&D at the Serum Institute of India, notes that “the ongoing phase III trial is one of the key trials in order to strengthen our scientific rationale”. Shaligram adds that he is “pleased to see that we have completed recruitment of all infants in such an important trial.”

Sources: Centers for Disease Control and Prevention, World Health Organization, Infectious Diseases

 

About the Author
Biology
Zoe (she/her) is a science writer and a scientist working in genomics. She received her B.S. from the University of Connecticut with a focus in Evolutionary Biology. At Labroots, she focuses on writing scientific content related to clinical research and diagnostics.
You May Also Like
AUG 04, 2022
Clinical & Molecular DX
Artificial Intelligence Shows Promise in Diagnosing Strokes
AUG 04, 2022
Artificial Intelligence Shows Promise in Diagnosing Strokes
Quick identification and intervention is critical in successfully treating a stroke. During a stroke, blood supply to th ...
SEP 08, 2022
Cardiology
Good Sleep Lowers Heart Disease and Stroke Risk
SEP 08, 2022
Good Sleep Lowers Heart Disease and Stroke Risk
About 90% people don't get good sleep, which may lead to a host of health risks.
SEP 01, 2022
Clinical & Molecular DX
A Common Bacterial Infection Could Lead to Colon Cancer
SEP 01, 2022
A Common Bacterial Infection Could Lead to Colon Cancer
Infections of the bacterium C. difficile can cause diarrhea and inflammation of the colon called colitis. It is estimate ...
SEP 19, 2022
Clinical & Molecular DX
Could Microplastics Disrupt Cellular Processes in Human Lungs and Livers?
SEP 19, 2022
Could Microplastics Disrupt Cellular Processes in Human Lungs and Livers?
Microplastics are tiny pieces of plastic that are shed from the larger pieces of plastic that we use every day. As plast ...
SEP 18, 2022
Cardiology
Adult ADHD Could Lead to Increased Chances of Cardiovascular Diseases
SEP 18, 2022
Adult ADHD Could Lead to Increased Chances of Cardiovascular Diseases
In a recent study published in World Psychiatry, an international team of researchers suggests that people with attentio ...
SEP 27, 2022
Clinical & Molecular DX
New Research Elucidates the Mechanism of Skin Cancer Metastasis to the Brain and Points to Groundbreaking Treatment
SEP 27, 2022
New Research Elucidates the Mechanism of Skin Cancer Metastasis to the Brain and Points to Groundbreaking Treatment
In advanced stages of skin cancer, patients develop brain metastases about 90% of the time. Though this is one of the mo ...
Loading Comments...